Target
Ketohexokinase
Ligand
BDBM50349726
Substrate
n/a
Meas. Tech.
Enzyme Assay
IC50
>10000±n/a nM
Citation
 Zhang, XAbad, MCGibbs, ACKuo, GSong, FSui, ZKuo, LC Indazole compounds useful as ketohexokinase inhibitors US Patent  US9771375 Publication Date 9/26/2017 
Target
Name:
Ketohexokinase
Synonyms:
Hepatic fructokinase | KHK | KHK_HUMAN | Ketohexokinase | Ketohexokinase (KHK) | Ketohexokinase (KHK) Isoform C
Type:
Enzyme Catalytic Domain
Mol. Mass.:
32521.64
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
298
Sequence:
MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV
  
Inhibitor
Name:
BDBM50349726
Synonyms:
CHEMBL1809153 | US8822447, 164 | US9771375, Example 164
Type:
Small organic molecule
Emp. Form.:
C19H15N3S
Mol. Mass.:
317.408
SMILES:
CSc1nn(-c2ccccc2)c2cc(ccc12)-c1ccncc1
Structure:
Search PDB for entries with ligand similarity: